The Gross Margin of Polus BioPharm Inc (007630.KS) is 9.76%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2020-12-31 | 9.76% |
| 2019-12-31 | 8.83% |
| 2018-12-31 | 9.14% |
| 2017-12-31 | 3.96% |
| 2016-12-31 | 5.48% |
| 2015-12-31 | 14.92% |
| 2014-12-31 | 25.54% |
| 2013-12-31 | 19.56% |
| 2012-12-31 | 28.71% |
| 2011-12-31 | 26.89% |